Roschier represented Karo Pharma in the deal. White & Case advised EQT, through EQT VIII and Karo Intressenter. Vinge has advised Nordea Bank Abp, filial i...
EQT’s Public Cash Offer For The Remaining Shares in Karo Pharma
Karo Pharma’s SEK 2.5 Billion Rights Issue
White & Case has advised Karo Pharma AB on the deal. Karo Pharma AB executed its fully underwritten SEK 2.5 billion (approximately US$260 million) rights issue....
Sylphar NV and Karo Pharma AB’s Purchase of Satin Naturel
Osborne Clarke advised Sylphar NV and Karo Pharma AB on the deal. Sylphar NV and Karo Pharma AB purchased the Satin Naturel business from Del Decus...
Karo Pharma’s €300 Million Acquisition of Sylphar
White & Case advised Karo Pharma on the deal. Roschier advised the sellers in the transaction. Karo Pharma executed the acquisition of Sylphar for €300 million...